Teva terminates partnership with CureTech
Israel-based Teva Pharmaceutical Industries has announced that it has terminated its partnership with CureTech.
Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced recently that they have signed a definitive agreement under which Teva will acquire Barr, the fourth largest generic drug company worldwide.